![]() |
市场调查报告书
商品编码
1416189
神经技术设备市场- 按产品类型(神经刺激、神经假体、神经感测、神经復健)、病症(癫痫、帕金森氏症、认知障碍)、最终用途(医院、ASC、家庭护理设施) - 全球预测,2023-2032 年Neurotech Devices Market - By Product Type (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation), Conditions (Epilepsy, Parkinsons Disease, Cognitive Disorder), End-use (Hospital, ASC, Homecare Facility)- Global Forecast, 2023-2032 |
在技术进步、神经系统疾病盛行率增加和人口老化的推动下,全球神经技术设备市场预计 2023 年至 2032 年CAGR将达到 13.8%。
根据世界卫生组织 2023 年的报告,神经系统疾病是全球第二大死因,每年导致 900 万人死亡,是导致残疾调整生命年的主要原因。随着人口老化的加剧和慢性神经系统疾病的增加,对创新和高效的神经技术解决方案的需求不断增加。此外,研发的快速步伐,特别是神经影像和神经调节技术的研发,正在推动市场向前发展。
整个神经技术设备市场根据产品、状况、创新、最终用途和地区进行分类。
在神经假体技术进步和医疗保健提供者意识不断提高的推动下,神经假体细分市场预计到 2032 年将实现良好成长。这些设备旨在透过直接与神经系统连接来恢復丧失的功能或补偿残疾。专注于开发更复杂和用户友好的神经假体有望进一步开闢新的成长领域。
在慢性疼痛盛行率不断上升和神经技术设备有效性的推动下,疼痛管理预计将在 2023 年至 2032 年期间稳步增长。这些设备,包括神经调节器和神经刺激器,正在成为治疗疼痛的有效解决方案。它们调节神经活动,缓解神经性疼痛或偏头痛等疾病的患者。人们对非侵入性和无药物疼痛管理方案的认识不断增强,正在促进产品的采用。
在人口老化、医疗保健支出增加以及对神经系统疾病认识不断提高的推动下,亚太地区神经技术设备市场预计到 2032 年将出现强劲增长。该地区各国政府和医疗保健组织正在投资基础设施和研究计划,以支援神经技术设备的开发和采用。不断的技术进步和合作将在未来几年促进亚太地区市场的成长。
The global neurotech devices market is expected to witness a CAGR of 13.8% during 2023 and 2032, driven by technological advancements, increasing prevalence of neurological disorders, and ageing population.
According to a report by WHO in 2023, neurological disorders, the second leading global cause of death account for a staggering 9 million annual deaths and are the leading contributors to disability-adjusted life years. With a growing aging population and a rise in chronic neurological conditions, there is an escalating demand for innovative and efficient neurotech solutions. Additionally, the rapid pace of R&D, particularly in neuroimaging and neuromodulation technologies, is propelling the market forward.
The overall neurotech devices market is classified based on product, condition, innovation, end-use, and region.
The neuroprostheses segment is set for decent growth through 2032, driven by advancements in neuroprostheses technology and growing awareness among healthcare providers. These devices are designed to restore lost functions or compensate for disabilities by interfacing directly with the nervous system. The focus on developing more sophisticated and user-friendly neuroprostheses is further expected to open new arenas for growth.
Pain management is expected to witness steady growth during 2023-2032, driven by increasing prevalence of chronic pain conditions and effectiveness of neurotech devices. These devices, including neuromodulators and neurostimulators, are emerging as effective solutions for managing pain. They modulate neural activity, offering relief to patients suffering from conditions such as neuropathic pain or migraines. The growing awareness of non-invasive and drug-free pain management options is fostering the product adoption.
Asia Pacific neurotech devices market is anticipated to witness robust growth through 2032 driven by aging population, increasing healthcare expenditures, and rising awareness about neurological disorders. Governments and healthcare organizations in the nations across the region are investing in infrastructure and research initiatives to support the development and adoption of neurotech devices. The constant technological advancements and collaborations will augment the APAC market growth in the coming years.